Publications by authors named "Jaap Groothoff"

Claim this Profile
F
Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
Yaacov Frishberg, Jeffrey M Saland, John C Lieske, Weiming Du, Martin Coenen, Jaap W Groothoff

Clin J Am Soc Nephrol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.
John C Lieske, Jaap W Groothoff, Yaacov Frishberg, Sander F Garrelfs, Dawn S Milliner

Kidney Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands.
Lisa J Deesker, Casper F M Franssen, Eiske Dorresteijn, Nicole C A J van de Kar, S Azam Nurmohamed, Jaap W Groothoff

Nephrol Dial Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transition of patients with hereditary nephropathies from pediatric to adult care.
Maria Vanessa Perez Gomez, George-Claudiu Costea, Laura Claus, Emilie Cornec-Le Gall, Albertien M van Eerde, Jaap Groothoff

Nephrol Dial Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary Hyperoxaluria.
Yaacov Frishberg, Jaap W Groothoff, Sally-Anne Hulton, Jerome Harambat, Julien Hogan

Nephrol Dial Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN.
Lisa J Deesker, Laila Oubram, Reham Almardini, Michelle A Baum, M Bonilla-Felix, Jaap W Groothoff

Nephrol Dial Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial.
Anne-Laure Sellier-Leclerc, Daniella Magen, Hadas Shasha-Lavsky, Eva Simkova, Arnaud Devresse, Jaap W Groothoff

Am J Kidney Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Foreign doctors in the Netherlands: increasingly better qualified for clinical practice].
Jaap Groothoff, Bauke Leijenaar, Jeroen van der Zwaag, Maartje van Vliet, Eva Stortelder

Ned Tijdschr Geneeskd· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PHYOX3: Nedosiran Long-Term Safety and Efficacy in Patients With Primary Hyperoxaluria Type 1.
John C Lieske, Gema Ariceta, Jaap W Groothoff, Graham Lipkin, Shabbir H Moochhala

Kidney Int Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New opportunities for accessing promising non-oncological orphan drugs.
Carla E M Hollak, Carelle C Reparon-Schuijt, Kathelijn Verdeyen, Lisa J Deesker, Jaap W Groothoff

Lancet Reg Health Eur· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.
Iris R Montez de Sousa, Marjolein Bonthuis, Anneke Kramer, Flor Angel Ordoñez, Francisco de la Cerda Ojeda, Jaap W Groothoff

Nephrol Dial Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient, Parental, and Health Professional Perspectives on Growth in Children With CKD.
Justin G Wu, Chandana Guha, Anastasia Hughes, Luca G Torrisi, Jonathan C Craig, Jaap Groothoff

Am J Kidney Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human glyoxylate metabolism revisited: New insights pointing to multi-organ involvement with implications for siRNA-based therapies in primary hyperoxaluria.
Ronald J A Wanders, Jaap W Groothoff, Lisa J Deesker, Eduardo Salido, Sander F Garrelfs

J Inherit Metab Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of four pricing models for orphan medicines: a case study for lumasiran.
Noa Rosenberg, Evert Manders, Sibren van den Berg, Lisa J Deesker, Sander F Garrelfs, Jaap W Groothoff

Orphanet J Rare Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory.
Barbara Cellini, Michelle A Baum, Yaacov Frishberg, Jaap W Groothoff, Peter C Harris

Kidney Int Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrafamilial Disease Heterogeneity in Primary Hyperoxaluria Type 1.
Lisa J Deesker, Hazal A Karacoban, Elisabeth L Metry, Sander F Garrelfs, Justine Bacchetta, Jaap W Groothoff

Kidney Int Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.
M Doortje Reijman, Tycho R Tromp, Barbara A Hutten, G Kees Hovingh, Dirk J Blom, Jaap W Groothoff

Lancet Child Adolesc Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial.
Jeffrey M Saland, John C Lieske, Jaap W Groothoff, Yaacov Frishberg, Hadas Shasha-Lavsky

Kidney Int Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN.
M Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, Klaus Arbeiter, Eldad J Dann

Atherosclerosis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nedosiran Safety and Efficacy in PH1: Interim Analysis of PHYOX3.
Jaap Groothoff, Anne-Laure Sellier-Leclerc, Lisa Deesker, Justine Bacchetta, Gesa Schalk

Kidney Int Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glyoxylate reductase: Definitive identification in human liver mitochondria, its importance for the compartment-specific detoxification of glyoxylate.
Sander F Garrelfs, Serhii Chornyi, Heleen Te Brinke, Jos Ruiter, Jaap Groothoff

J Inherit Metab Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical screening algorithm for primary hyperoxaluria type 1 in adults on dialysis.
Pietro Manuel Ferraro, Viola D'Ambrosio, Giovanni Gambaro, Daniela Giachino, Jaap Groothoff

Nephrol Dial Transplant· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy." Kidney International, 2023;104:203-204.
Elisabeth L Metry, Lisa J Deesker, Sander F Garrelfs, Michiel J S Oosterveld, Kerensa M Beekman, Jaap W Groothoff

Kidney Int· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPN.
M Doortje Reijman, D Meeike Kusters, Jaap W Groothoff, Klaus Arbeiter, Eldad J Dann

medRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium.
Elisabeth L Metry, Sander F Garrelfs, Lisa J Deesker, Cecile Acquaviva, Viola D'Ambrosio, Jaap W Groothoff

Kidney Int Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis